InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Explore the full record of transactions filed by Reilly Thomas Charles, Chief Financial Officer. Officer active across 1 companies, notably Cara Therapeutics, Inc.. In total, 8 filings have been published. Total volume traded: €69k. The latest transaction was filed on 3 March 2022 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations8 total
€20,9322,044 shares@ €10.240930.5% of flow
Common Stock
SEC:0001209191-22-016438:0·
020,000 shares0
Common Stock
SEC:0001209191-22-013992:0·
011,170 shares0
Common Stock
SEC:0001209191-21-070801·
011,170 shares0
Common Stock
SEC:0001209191-21-070801:0·
€23,8571,982 shares@ €12.0371100.0% of flow
Common Stock
SEC:0001209191-21-054303·
€23,8571,982 shares@ €12.037134.8% of flow
Common Stock
SEC:0001209191-21-054303:0·
05,334 shares0
Common Stock
SEC:0001209191-21-053538·
05,334 shares0
Common Stock
SEC:0001209191-21-053538:0·
8 of 8 declarations
About Reilly Thomas Charles
Thomas Charles Reilly is the Chief Financial Officer of Cara Therapeutics, Inc. In this role, he oversees the financial operations of the company, including accounting, financial planning, and financial reporting. Reilly brings significant expertise in the pharmaceutical sector, contributing to performance optimization and resource management. His role is essential in ensuring the growth of Cara Therapeutics.
